News Daily News CMS Greenlights Reimbursement for Renal Denervation Systems L.A. McKeown October 29, 2025
Presentation TCT 2025 Symplicity Spyral™ in the Real World: Results from the Cleveland Clinic Presenter: Aravinda Nanjundappa October 27, 2025
Presentation TCT 2025 University of Pennsylvania's Hypertension Program Presenter: Raymond R. Townsend October 27, 2025
Presentation TCT 2025 Patient Selection and Shared Decision Making Presenter: Raymond R. Townsend October 27, 2025
Presentation TCT 2025 Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study Presenter: David E. Kandzari October 26, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Conference News ESC 2024 New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower Yael L. Maxwell September 04, 2024
News Daily News Study Supports Cost-effectiveness of Renal Denervation for Hypertension Todd Neale August 23, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News Symplicity Spyral Approved: FDA Clears Second Renal Denervation System Todd Neale November 20, 2023